Insight “Building a More Reliable AI Ecosystem” – Interview with Datumo CEO David Kim David Kim, CEO of Datumo, spoke with SKT Newsroom on the outcomes of participating in the K-AI Alliance and the role of Datumo. 2025.10.21
Insight Using AI to Match Optimal Anti-Cancer Drugs to Cancer Patients – Interview with ImpriMed CEO Sungwon Lim SKT Newsroom interviewed ImpriMed CEO Sungwon Lim regarding the development process of precision medicine solutions and the achievements from participating in the K-AI Alliance. 2025.07.22
